热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Pacific Blue™ anti-mouse/human CD45R/B220 An
产品名称：
Pacific Blue™ anti-mouse/human CD45R/B220 An
产品类别：
抗体
产品编号：
103230
产品应用：
103230
[价格]
规格 价格 库存
25µg ￥ 1316 1

产品详情

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Abelson murine leukemia virus-induced pre-B tumor cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with Pacific Blue? under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 ?g per 106 cells in 100 ?l volume. It is highly recommended that the reagent be titrated for optimal performance for each application.

* Pacific Blue? has a maximum emission of 455 nm when it is excited at 405 nm. Prior to using Pacific Blue? conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.


Alexa Fluor? and Pacific Blue? are trademarks of Life Technologies Corporation.

View full statement regarding label licenses
Excitation Laser
Violet Laser (405 nm)
Application Notes

Clone RA3-6B2 has been described to react with an epitope on the extracellular domain of the transmembrane CD45 glycoprotein which is dependent upon the expression of exon A and specific carbohydrate residues. Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro and in vivo modulation of B cell responses2-4, immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections5,6, and spatial biology (IBEX)14,15.

Application References

(PubMed link indicates BioLegend citation)
  1. Coffman RL. 1982. Immunol. Rev. 69:5. (IP)
  2. George A, et al. 1994. J. Immunol. 152:1014. (Activ)
  3. Asensi V, et al. 1989. Immunology 68:204. (Activ)
  4. Domiati-Saad R, et al. 1993. J. Immunol. 151:5936. (Activ)
  5. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  6. Monteith CE, et al. 1996. Can. J. Vet. Res. 60:193. (IHC)
  7. Shih FF, et al. 2006. J. Immunol. 176:3438. (FC)
  8. Chang C L-T, et al. 2007. J. Immunol. 178:6984.
  9. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  10. Lang GL, et al. 2008. Blood 111:2158. PubMed
  11. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  12. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
  13. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
  14. Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
  15. Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
Product Citations
  1. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  2. Chen CC, et al. 2021. J Exp Med. 218:. PubMed
  3. Schmid C, et al. 2015. J Exp Med. 212:775. PubMed
  4. Vijayan K, et al. 2021. Cell Reports. 36(5):109489. PubMed
  5. Makdasi E, et al. 2009. J Immunol. 182:6143. PubMed
  6. Benhamou D, et al. 2018. Front Immunol. 2.260416667. PubMed
  7. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  8. Grosjean F, et al. 2015. PLoS One. 10: 0133917. PubMed
  9. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  10. Murphy M, et al. 2017. Eur J Immunol. 47:880. PubMed
  11. Hung PJ, et al. 2018. Mol Cell. 71:332. PubMed
  12. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  13. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  14. Gajdasik DW, et al. 2020. Nat Commun. 2.834027778. PubMed
  15. Vazquez S, et al. 2015. Exp Hematol. 43: 578-585. PubMed
  16. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  17. Kat I, et al. 2010. Int Immunol. 0.986805556. PubMed
  18. Chopin M et al. 2018. Immunity. 50(1):77-90 . PubMed
  19. Domeier P, et al. 2016. J Exp Med. 213: 715 - 732. PubMed
  20. Günal-Sad?k G, et al. 2014. PLoS One. 9:111748. PubMed
  21. Soni C, et al. 2014. J Immunol. 193:4400. PubMed
  22. Simerska P, et al. 2014. Vaccine. 32:4743. PubMed
  23. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  24. Krishnamurthy B, et al. 2015. Diabetes. 64: 3229-3238. PubMed
  25. Onodera T, et al. 2016. J Immunol. 196: 4172 - 4184. PubMed
  26. Courtney AH et al. 2017. Molecular cell. 67(3):498-511 . PubMed
  27. Wilder BK, et al. 2022. NPJ Vaccines. 7:58. PubMed
  28. Jyh Liang Hor, William R. Heath, Scott N. Mueller 2017. Sci Rep. 7:41091. PubMed
  29. Minamitani T, et al. 2015. Proc Natl Acad Sci U S A. 112: 11612-11617. PubMed
  30. Uddback I, et al. 2016. Sci Rep. 6:20137. PubMed
  31. Soni C, et al. 2020. Immunity. 52(6):1022-1038.e7. PubMed
  32. Abbott RK, et al. 2018. Immunity. 48:133. PubMed
  33. K?lin S et al. 2017. Cell metabolism. 26(3):475-492 . PubMed
  34. Lin J, et al. 2021. Nat Commun. 12:5321. PubMed
  35. Georgoudaki A, et al. 2016. Cell Rep. 15: 2000-2011. PubMed
  36. Perry JL, et al. 2020. ACS Nano. 5.583333333. PubMed
  37. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  38. Alexandre YO, et al. 2020. Cell Reports. 33(13):108567. PubMed
  39. Wang X, et al. 2021. EMBO J. 40:e105926. PubMed
  40. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  41. Sato K, et al. 2017. J Immunol. 10.4049/jimmunol.1602005. PubMed
  42. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  43. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  44. Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed
  45. Teo TH, et al. 2018. Nat Commun. 9:3905. PubMed
  46. Tanaka Y, et al. 2017. J Immunol. 199:4016. PubMed
  47. Raju S, et al. 2020. Cell Reports. 29(9):2556-2564.e3.. PubMed
  48. Jeljeli M, et al. 2021. Front Immunol. 12:670776. PubMed
  49. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  50. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  51. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  52. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  53. Baglaenko Y, et al. 2016. PLoS One. 11: 0150515. PubMed
  54. Nishimori J, et al. 2012. Infect Immun . 80:4398. PubMed
  55. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  56. Ilsley M, et al. 2017. Nucleic Acids Research. 10.1093/nar/gkx441. PubMed
  57. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  58. McPhee C, et al. 2013. J Immunol. 191:4581. PubMed
  59. Wong E, et al. 2015. J Immunol. 194:4130. PubMed
  60. Kato Y, et al. 2015. J Immunol. 195: 1006-1014. PubMed
  61. Hamilton J,et al. 2017. J Immunol. 10.4049/jimmunol.1700888. PubMed
  62. Gaya M et al. 2018. Cell. 172(3):517-533 . PubMed
  63. Jaitin DA et al. 2016. Cell. 167(7):1883-1896 . PubMed
  64. Chao JL, et al. 2021. Cell Rep Med. 2:100399. PubMed
  65. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  66. Baptista M, et al. 2016. Nat Commun. 7:12175. PubMed
  67. Eilat E 2013. J Immunol. 190:1472. PubMed
  68. Smith LK, et al. 2021. Elife. 10:. PubMed
  69. Adachi Y, et al. 2015. J Exp Med. 212: 1709-1723. PubMed
  70. Serr I, et al. 2016. Nat Commun. 7:10991. PubMed
  71. Sch?fer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  72. Fast EM, et al. 2021. Elife. 10:. PubMed
  73. Yoshikawa S, et al. 2016. Sci Rep. 6:18738. PubMed
  74. Carbonetti S et al. 2017. Journal of immunological methods. 448:66-73 . PubMed
  75. Quijano-Rubio A, et al. 2022. Nat Biotechnol. Online ahead of print. PubMed
  76. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
RRID
AB_492877 (BioLegend Cat. No. 103230) AB_492876 (BioLegend Cat. No. 103227)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

B cells, T cell subset, NK cell subset

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Cell Type
B cells, NK cells, T cells
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID 5788 View all products for this Gene ID
UniProt
View information about CD45R on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线